Search Results

0 results for 'AbbVie'

You can use to get even better search results
July 26, 2022 | Law.com

Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.
4 minute read
July 26, 2022 | Texas Lawyer

Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

Teva negotiated the deal with the plaintiffs executive committee in the opioid multidistrict litigation, along with a "working group" of attorneys general of 12 states, including Texas, California, New York and Pennsylvania.
4 minute read
July 26, 2022 | The Recorder

Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement

Teva negotiated the deal with the plaintiffs executive committee in the opioid multidistrict litigation, along with a "working group" of attorneys general of 12 states, including California, New York, Pennsylvania and Texas.
4 minute read
July 19, 2022 | New York Law Journal

The 2022 GC Compensation Survey: New York Legal Chiefs Get a Post-Pandemic Pay Bump

"The market remains very competitive. There are incredible amounts of hiring. Money is being thrown at everyone," said Deborah Ben-Canaan, senior practice leader for in-house counsel recruiting at Major, Lindsey & Africa.
8 minute read
July 19, 2022 | Corporate Counsel

The 2022 GC Compensation Survey: Legal Chief Pay Spikes After Pandemic Pause

"The market remains very competitive. There are incredible amounts of hiring. Money is being thrown at everyone," said Deborah Ben-Canaan, senior practice leader for in-house counsel recruiting at Major, Lindsey & Africa.
8 minute read
July 15, 2022 | The Legal Intelligencer

King & Spalding Defends AbbVie, Allergan Over Claims Surgical Scaffold Caused Cancer

This suit was surfaced by Law.com Radar. Read the complaint here.
1 minute read
July 12, 2022 | The Recorder

Allergan, Teva Settle Opioid Trial As Closing Arguments Begin in San Francisco

The two drug companies have agreed to pay $54 million to settle San Francisco's opioid trial on Tuesday, but closing arguments continue against a third defendant, Walgreens.
4 minute read
NYS v. Dayan
Publication Date: 2022-07-07
Practice Area: Government
Industry:
Court: Supreme Court, New York
Judge: Justice James D'Auguste
Attorneys:
For plaintiff:
For defendant:
Case number: 101426/2014

Court Dismisses Relator's False Claims Court Dismisses Relator's False Claims

May 18, 2022 | The Recorder

California's Board Diversity Laws Have Been Struck Down. What Does It Mean For Corporate Initiatives?

One lawyer predicts that the unraveling of California's board diversity statutes could ultimately strengthen corporate boardroom diversity efforts by paving the "way for a more defensible model for the future."
3 minute read
May 17, 2022 | Corporate Counsel

What GCs Should Know About California's Blocked Board Diversity Laws

It's possible, but unlikely, that activist investors and groups could successfully leverage the recent California rulings to go after companies that have diversity policies.
3 minute read

TRENDING STORIES